Literature DB >> 24705196

Chemerin, a novel player in inflammatory bowel disease.

C Buechler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24705196      PMCID： PMC4085516          DOI： 10.1038/cmi.2014.14

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  12 in total

Review 1.  "Metabolic aspects" in inflammatory bowel diseases.

Authors:  Arthur Kaser; Herbert Tilg
Journal:  Curr Drug Deliv       Date:  2012-07       Impact factor: 2.565

Review 2.  Intestinal macrophages - specialised adaptation to a unique environment.

Authors:  Calum C Bain; Allan McI Mowat
Journal:  Eur J Immunol       Date:  2011-09       Impact factor: 5.532

Review 3.  Chemerin: at the crossroads of inflammation and obesity.

Authors:  Matthew C Ernst; Christopher J Sinal
Journal:  Trends Endocrinol Metab       Date:  2010-11       Impact factor: 12.015

Review 4.  Experimental models of inflammatory bowel disease.

Authors:  C O Elson; R B Sartor; G S Tennyson; R H Riddell
Journal:  Gastroenterology       Date:  1995-10       Impact factor: 22.682

5.  Chemokine-like receptor 1 expression by macrophages in vivo: regulation by TGF-beta and TLR ligands.

Authors:  Brian A Zabel; Takao Ohyama; Luis Zuniga; Ji-Yun Kim; Brent Johnston; Samantha J Allen; David G Guido; Tracy M Handel; Eugene C Butcher
Journal:  Exp Hematol       Date:  2006-08       Impact factor: 3.084

6.  Epithelial cells in fetal intestine produce chemerin to recruit macrophages.

Authors:  Akhil Maheshwari; Ashish R Kurundkar; Sadiq S Shaik; David R Kelly; Yolanda Hartman; Wei Zhang; Reed Dimmitt; Shehzad Saeed; David A Randolph; Charles Aprahamian; Geeta Datta; Robin K Ohls
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-05-14       Impact factor: 4.052

7.  Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease.

Authors:  Johanna Weigert; Florian Obermeier; Markus Neumeier; Josef Wanninger; Michael Filarsky; Sabrina Bauer; Charalampos Aslanidis; Gerhard Rogler; Claudia Ott; Andreas Schäffler; Jürgen Schölmerich; Christa Buechler
Journal:  Inflamm Bowel Dis       Date:  2010-04       Impact factor: 5.325

8.  Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis.

Authors:  Tsukasa Ishida; Masaru Yoshida; Makoto Arita; Yosuke Nishitani; Shin Nishiumi; Atsuhiro Masuda; Shigeto Mizuno; Tetsuya Takagawa; Yoshinori Morita; Hiromu Kutsumi; Hideto Inokuchi; Charles N Serhan; Richard S Blumberg; Takeshi Azuma
Journal:  Inflamm Bowel Dis       Date:  2010-01       Impact factor: 5.325

Review 9.  The genetics and immunopathogenesis of inflammatory bowel disease.

Authors:  Judy H Cho
Journal:  Nat Rev Immunol       Date:  2008-06       Impact factor: 53.106

10.  The chemerin/ChemR23 system does not affect the pro-inflammatory response of mouse and human macrophages ex vivo.

Authors:  Benjamin Bondue; Olivier De Henau; Souphalone Luangsay; Thalie Devosse; Patricia de Nadaï; Jean-Yves Springael; Marc Parmentier; Olivier Vosters
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240
View more
  6 in total

1.  Evaluation of chemerin and its receptors, ChemR23 and CCRL2, in gingival tissues with healthy and periodontitis.

Authors:  Erkan Özcan; N Işıl Saygun; Rahşan Ilıkçı; Yıldırım Karslıoğlu; Uğur Muşabak; Sait Yeşillik
Journal:  Odontology       Date:  2017-02-23       Impact factor: 2.634

2.  Serum chemerin levels are independently associated with quality of life in colorectal cancer survivors: A pilot study.

Authors:  Jee-Yon Lee; Mi-Kyung Lee; Nam-Kyu Kim; Sang-Hui Chu; Duk-Chul Lee; Hye-Sun Lee; Ji-Won Lee; Justin Y Jeon
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

Review 3.  Adipokines and the role of visceral adipose tissue in inflammatory bowel disease.

Authors:  Thomas Karrasch; Andreas Schaeffler
Journal:  Ann Gastroenterol       Date:  2016-09-06

Review 4.  Chemerin Isoforms and Activity in Obesity.

Authors:  Christa Buechler; Susanne Feder; Elisabeth M Haberl; Charalampos Aslanidis
Journal:  Int J Mol Sci       Date:  2019-03-05       Impact factor: 5.923

Review 5.  Impact of Obesity on the Course of Management of Inflammatory Bowel Disease-A Review.

Authors:  Agata Michalak; Beata Kasztelan-Szczerbińska; Halina Cichoż-Lach
Journal:  Nutrients       Date:  2022-09-25       Impact factor: 6.706

Review 6.  Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases.

Authors:  Lucia Recinella; Giustino Orlando; Claudio Ferrante; Annalisa Chiavaroli; Luigi Brunetti; Sheila Leone
Journal:  Front Physiol       Date:  2020-10-30       Impact factor: 4.566
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.